Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (UG3/UH3 Clinical Trial Required)

Funding Agency:
National Institutes of Health

Violence affects people of all ages and its impact is far-reaching. It is a leading cause of death and nonfatal injuries in the United States and constitutes a major public health crisis, especially among young people, and in particular among racial/ethnic minority, sexual and gender minority (SGM) and disability populations. NIH is committed to supporting research that identifies innovative prevention approaches to reduce firearm and related violence, injury and mortality. Within the legislative mandates and limitations of NIH funding (NOT-OD-21-058NOT-OD-21-056), this initiative will support a network of research projects to develop and test interventions at the community or community organization level that aim to prevent firearm and related violence, injury and mortality.

This FOA solicits bi-phasic research projects proposed in UG3/UH3 Phased Innovation Awards Cooperative Agreement applications. Funding for the UG3 phase (phase I) will be used to demonstrate sufficient preparation, feasibility and capacity to meet foundational milestone targets specific to the work proposed. A UG3 project that meets its milestones will be administratively considered by NIH and prioritized for transition to the UH3 award (phase II). Applicants responding to this FOA must address specific aims and milestones for both the UG3 and UH3 phases.


  • Letter of Intent Due Date(s): 30 days before application due date

  • Application Due Date: March 17, 2023

PAR-23-066 Expiration Date March 18, 2023

Agency Website

Amount Description

Application budgets are limited to $500,000 per year in direct cost for UG3 (phase 1), and $1,000,000 per year in direct costs for UH3 (phase 2).

The maximum project period is 5 years. This includes up to 2 years for the UG3 (phase 1) and up to 4 years for the UH3 (phase 2) with the total project period for both the UG3 and UH3 phases not to exceed 5 years.

Funding Type





Community Outreach and Engagement
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

March 17, 2023